BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16446282)

  • 1. A diet-induced mouse model for glutaric aciduria type I.
    Zinnanti WJ; Lazovic J; Wolpert EB; Antonetti DA; Smith MB; Connor JR; Woontner M; Goodman SI; Cheng KC
    Brain; 2006 Apr; 129(Pt 4):899-910. PubMed ID: 16446282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
    Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
    Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal neuronal death mediated by astrocytes from the Gcdh-/- mouse model of glutaric acidemia type I.
    Olivera-Bravo S; Ribeiro CA; Isasi E; Trías E; Leipnitz G; Díaz-Amarilla P; Woontner M; Beck C; Goodman SI; Souza D; Wajner M; Barbeito L
    Hum Mol Genet; 2015 Aug; 24(16):4504-15. PubMed ID: 25968119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.
    Biagosch C; Ediga RD; Hensler SV; Faerberboeck M; Kuehn R; Wurst W; Meitinger T; Kölker S; Sauer S; Prokisch H
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2220-2228. PubMed ID: 28545977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency.
    Sauer SW; Okun JG; Fricker G; Mahringer A; Müller I; Crnic LR; Mühlhausen C; Hoffmann GF; Hörster F; Goodman SI; Harding CO; Koeller DM; Kölker S
    J Neurochem; 2006 May; 97(3):899-910. PubMed ID: 16573641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.
    Harting I; Neumaier-Probst E; Seitz A; Maier EM; Assmann B; Baric I; Troncoso M; Mühlhausen C; Zschocke J; Boy NP; Hoffmann GF; Garbade SF; Kölker S
    Brain; 2009 Jul; 132(Pt 7):1764-82. PubMed ID: 19433437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
    Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
    J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1.
    Thies B; Meyer-Schwesinger C; Lamp J; Schweizer M; Koeller DM; Ullrich K; Braulke T; Mühlhausen C
    Biochim Biophys Acta; 2013 Oct; 1832(10):1463-72. PubMed ID: 23623985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Lasting High Lysine Diet Aggravates White Matter Injury in Glutaryl-CoA Dehydrogenase Deficient (Gcdh-/-) Mice.
    Olivera-Bravo S; Seminotti B; Isasi E; Ribeiro CA; Leipnitz G; Woontner M; Goodman SI; Souza D; Barbeito L; Wajner M
    Mol Neurobiol; 2019 Jan; 56(1):648-657. PubMed ID: 29779173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance to clinical guidelines determines outcome in glutaric aciduria type I in the era of newborn screening.
    Höliner I; Simma B; Reiter A; Sass JO; Zschocke J; Huemer M
    Klin Padiatr; 2010; 222(1):35-7. PubMed ID: 20084589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine intake and neurotoxicity in glutaric aciduria type I: towards a rationale for therapy?
    Kölker S; Sauer SW; Okun JG; Hoffmann GF; Koeller DM
    Brain; 2006 Aug; 129(Pt 8):e54. PubMed ID: 16870879
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Amaral AU; Cecatto C; Seminotti B; Ribeiro CA; Lagranha VL; Pereira CC; de Oliveira FH; de Souza DG; Goodman S; Woontner M; Wajner M
    Brain Res; 2015 Sep; 1620():116-29. PubMed ID: 25998543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboflavin-responsive glutaryl CoA dehydrogenase deficiency.
    Chalmers RA; Bain MD; Zschocke J
    Mol Genet Metab; 2006 May; 88(1):29-37. PubMed ID: 16377226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice.
    Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Leipnitz G; Souza DO; Wajner M
    Neurochem Int; 2019 Oct; 129():104467. PubMed ID: 31121257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I.
    Herskovitz M; Goldsher D; Sela BA; Mandel H
    Neurology; 2013 Aug; 81(9):849-50. PubMed ID: 23884036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutaric aciduria type 1 presenting with epilepsy.
    McClelland VM; Bakalinova DB; Hendriksz C; Singh RP
    Dev Med Child Neurol; 2009 Mar; 51(3):235-9. PubMed ID: 19260933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I.
    Koeller DM; Woontner M; Crnic LS; Kleinschmidt-DeMasters B; Stephens J; Hunt EL; Goodman SI
    Hum Mol Genet; 2002 Feb; 11(4):347-57. PubMed ID: 11854167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of brain redox homeostasis in glutaryl-CoA dehydrogenase deficient mice treated with high dietary lysine supplementation.
    Seminotti B; Amaral AU; da Rosa MS; Fernandes CG; Leipnitz G; Olivera-Bravo S; Barbeito L; Ribeiro CA; de Souza DO; Woontner M; Goodman SI; Koeller DM; Wajner M
    Mol Genet Metab; 2013 Jan; 108(1):30-9. PubMed ID: 23218171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-causing missense mutations affect enzymatic activity, stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH).
    Keyser B; Mühlhausen C; Dickmanns A; Christensen E; Muschol N; Ullrich K; Braulke T
    Hum Mol Genet; 2008 Dec; 17(24):3854-63. PubMed ID: 18775954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonium accumulation and chemokine decrease in culture media of Gcdh
    Cudré-Cung HP; Remacle N; do Vale-Pereira S; Gonzalez M; Henry H; Ivanisevic J; Schmiesing J; Mühlhausen C; Braissant O; Ballhausen D
    Mol Genet Metab; 2019 Apr; 126(4):416-428. PubMed ID: 30686684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.